
On being asked about the status of the vaccine, company's subsidiary Gennova is developing for COVID-19, Mehta said, "We are developing the vaccine and have completed the phase-1 trials.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fJGOEj
via
IFTTT
0 comments:
Post a Comment